Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Prostatic Neoplasms × Tacrolimus × Clear all

Sponsor

Conditions

Myelodysplastic Syndromes 38 Leukemia, Myeloid, Acute 38 Hodgkin Disease 36 Leukemia 33 Leukemia, Lymphocytic, Chronic, B-Cell 32 Precursor Cell Lymphoblastic Leukemia-Lymphoma 31 Lymphoma 31 Multiple Myeloma 30 Lymphoma, Non-Hodgkin 30 Lymphoma, Follicular 25 Lymphoma, Mantle-Cell 23 Lymphoma, Large B-Cell, Diffuse 23 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 21 Hematologic Neoplasms 21 Graft vs Host Disease 21 Myeloproliferative Disorders 20 Lymphoma, B-Cell, Marginal Zone 20 Leukemia, Myelomonocytic, Chronic 19 Leukemia, Myeloid, Accelerated Phase 19 Congenital Abnormalities 18 Burkitt Lymphoma 18 Primary Myelofibrosis 16 Neoplasms, Plasma Cell 15 Leukemia, Myeloid, Chronic-Phase 15 Lymphoma, Large-Cell, Immunoblastic 14 Waldenstrom Macroglobulinemia 13 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 13 Blast Crisis 13 Lymphoma, Large-Cell, Anaplastic 11 Anemia, Refractory, with Excess of Blasts 11

Interventions

Prednisone 90 Docetaxel 77 Leuprolide 68 enzalutamide 56 Abiraterone Acetate 55 bicalutamide 40 Goserelin 40 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 36 Radiotherapy 30 abiraterone 20 apalutamide 19 sipuleucel-T 18 luprolide acetate gel depot 18 gallium 68 PSMA-11 18 Gonadotropin-Releasing Hormone 18 Radiosurgery 16 Magnetic Resonance Spectroscopy 16 Triptorelin Pamoate 15 Androgen Antagonists 15 cabazitaxel 14 Radiotherapy, Intensity-Modulated 13 pembrolizumab 12 Prednisolone 12 Dexamethasone 12 Brachytherapy 12 cabozantinib 11 Radiation 11 Dutasteride 11 Carboplatin 11 radium Ra 223 dichloride 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡